A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

T. J. Bowker, T. C. Clayton, J. Ingham, N. R. McLennan, H. L. Hobson, S. D. Pyke, B. Schofield, D. A. Wood

Cardiac Medicine, Imperial College of Science, Technology and Medicine, Londo

OBJECTIVE: To measure the potential for secondary prevention of coronary disease in the United Kingdom. DESIGN: Cross sectional survey of a representative sample of coronary patients from a retrospective review of hospital medical records and patient interview and examination. SETTING: Stratified random sample of 12 specialist cardiac centres and 12 district general hospitals drawn from 34 specialist cardiac centres and 261 district general hospitals in 12 geographic areas in the United Kingdom. SUBJECTS: 2583 patients < or = 70 yr; 25 consecutive males and 25 consecutive females identified retrospectively in each of four diagnostic categories: coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, acute myocardial infarction, and acute myocardial ischaemia without evidence of infarction. MAIN OUTCOME MEASURES: Risk factor recording and management in medical records; the prevalence and control of risk factors at interview six months after the procedure or event. RESULTS: Recording of coronary risk factors in patient's records was incomplete and this varied by risk factor. Smoking habit and blood pressure were most completely recorded, whereas a history of hyperlipidaemia and blood cholesterol concentrations were least complete. Risk factor records were more likely to be complete in cardiac centres than in district hospitals. At interview 10% to 27% of patients were still smoking cigarettes and 75% remained overweight, females more severely so. Up to a quarter of patients remained hypertensive, males more severely so than females. Over three quarters had a total cholesterol > 5.2 mmol/l. In patients on medication for blood pressure, cholesterol or glucose, risk factor profiles were little better than in those who were not. Only about one patient in three was taking a beta blocker after infarction. Up to a fifth of patients who had had acute myocardial ischaemia were not taking aspirin at follow up. CONCLUSIONS: There is considerable potential to reduce the risk of a further major ischaemic event in patients with established coronary disease. This can be achieved by effective lifestyle intervention, the rigorous management of blood pressure and cholesterol, and the appropriate use of prophylactic drugs.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Quinn, T. (2009). A decade of improvement for cardiac patients in England. Journal of Research in Nursing 14: 199-202  
• Idanpaan-Heikkila, U. M., Lambie, L., Mattke, S., McLaughlin, V., Palmer, H., Tu, J. V. (2006). Selecting indicators for the quality of cardiac care at the health system level in Organization for Economic Co-operation and Development countries. Int J Qual Health Care 18: 39-44 [Abstract] [Full Text]  
• Karthik, S., Tahir, N., Thakur, B., Nair, U. (2006). Risk factor awareness and secondary prevention of coronary artery disease: are we doing enough?. ICVTS 5: 268-271 [Abstract] [Full Text]  
• Jaiveer, P. K, Jaiveer, S., Jujjavarapu, S. B, Morrissey, J., White, J., Gadsby, R., Patel, V. (2006). Improvements in clinical diabetes care in the first year of the new General Medical Services contract in the UK. British Journal of Diabetes & Vascular Disease 6: 45-48 [Abstract]  
• Diamantopoulos, E. J., Athyros, V. G., Yfanti, G. K., Migdalis, E. N., Elisaf, M., Vardas, P. E., Manolis, A. S., Karamitsos, D. T., Ganotakis, E. S., Hatseras, D., OLYMPIC Study Group, (2005). The contrOL of dYslipideMia in outPatIent clinics in GreeCe (Olympic) Study. ANGIOLOGY 56: 731-741 [Abstract]  
• Fox, D J, Kibiro, M, Eichhofer, J, Curzen, N P (2005). Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?. Postgrad. Med. J. 81: 401-403 [Abstract] [Full Text]  
• Leslie, S J, McKee, S P, Imray, E A, Denvir, M A (2005). Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract. Postgrad. Med. J. 81: 321-326 [Abstract] [Full Text]  
• Martin, T N, Irving, R J, Sutherland, M, Sutherland, K, Bloomfield, P (2005). Improving secondary prevention in coronary bypass patients: closing the audit loop. Heart 91: 456-459 [Abstract] [Full Text]  
• Carruthers, K F, Dabbous, O H, Flather, M D, Starkey, I, Jacob, A, MacLeod, D, Fox, K A A, on behalf of the GRACE Investigators, (2005). Contemporary management of acute coronary syndromes: does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart 91: 290-298 [Abstract] [Full Text]  
• McLeod, A.L., Brooks, L., Taylor, V., Currie, P.F., Dewhurst, N.G. (2004). Secondary prevention for coronary artery disease. QJM 97: 127-131 [Abstract] [Full Text]  
• Vale, M. J., Jelinek, M. V., Best, J. D., Dart, A. M., Grigg, L. E., Hare, D. L., Ho, B. P., Newman, R. W., McNeil, J. J. (2003). Coaching patients On Achieving Cardiovascular Health (COACH): A Multicenter Randomized Trial in Patients With Coronary Heart Disease. Arch Intern Med 163: 2775-2783 [Abstract] [Full Text]  
• Donnan, P. T, Dougall, H. T, Sullivan, F. M (2003). Optimal strategies for identifying patients with myocardial infarction in general practice. Fam Pract 20: 706-710 [Abstract] [Full Text]  
• Jaiveer, P., Saraswathy, J., Lee, J. D, Morrissey, J., Patel, V. (2003). The Alphabet strategy -- a tool to achieve clinical trial standards in routine practice?. British Journal of Diabetes & Vascular Disease 3: 410-413 [Abstract]  
• Unal, B, Critchley, J A, Capewell, S (2003). Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart disease. J. Epidemiol. Community Health 57: 530-535 [Abstract] [Full Text]  
• Maggioni, A P, Sinagra, G, Opasich, C, Geraci, E, Gorini, M, Gronda, E, Lucci, D, Tognoni, G, Balli, E, Tavazzi, L (2003). Treatment of chronic heart failure with {beta} adrenergic blockade beyond controlled clinical trials: the BRING-UP experience. Heart 89: 299-305 [Abstract] [Full Text]  
• (2002). References. Circulation 106: 3373-3421 [Full Text]  
• Hobbs, F. R., Erhardt, L. (2002). Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 19: 596-604 [Abstract] [Full Text]  
• Amar, J, Chamontin, B, Ferrieres, J, Danchin, N, Grenier, O, Cantet, C, Cambou, J-P (2002). Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study. Heart 88: 587-591 [Abstract] [Full Text]  
• Wood, D A (2002). Preventing clinical heart failure: the rationale and scientific evidence. Heart 88: ii15-22 [Full Text]  
• Underwood, P, Beck, P (2002). Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues. Qual Saf Health Care 11: 230-232 [Abstract] [Full Text]  
• Tsuyuki, R. T., Johnson, J. A., Teo, K. K., Simpson, S. H., Ackman, M. L., Biggs, R. S., Cave, A., Chang, W.-C., Dzavik, V., Farris, K. B., Galvin, D., Semchuk, W., Taylor, J. G., for the Study of Cardiovascular Risk Intervention, (2002). A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med 162: 1149-1155 [Abstract] [Full Text]  
• Egred, M., Corr, L. (2002). Establishment and feasibility of community-based general-practitioner-led cardiology clinics. QJM 95: 299-303 [Abstract] [Full Text]  
• Harrop, J, Donnelly, R, Rowbottom, A, Holt, M, Scott, A R (2002). Improvements in total mortality and lipid levels after acute myocardial infarction in an English health district (1995-1999). Heart 87: 428-431 [Abstract] [Full Text]  
• de Lorgeril, M., Salen, P., Defaye, P., Mabo, P., Paillard, F. (2002). Dietary prevention of sudden cardiac death. Eur Heart J 23: 277-285 [Full Text]  
• Drummond, A., Kwok, S., Morgan, J., Durrington, P.N. (2002). Costs of aspirin and statins in general practice. QJM 95: 23-26 [Abstract] [Full Text]  
• Fowler, G. (2001). Commentary: GP check-ups' still of limited value. Int J Epidemiol 30: 942-943 [Full Text]  
• McHugh, F, Lindsay, G M, Hanlon, P, Hutton, I, Brown, M R, Morrison, C, Wheatley, D J (2001). Nurse led shared care for patients on the waiting list for coronary artery bypass surgery: a randomised controlled trial. Heart 86: 317-323 [Abstract] [Full Text]  
• Qureshi, A. I., Suri, M. F. K., Guterman, L. R., Hopkins, L. N. (2001). Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US Population: Report From the Third National Health and Nutrition Examination Survey. Arch Intern Med 161: 1621-1628 [Abstract] [Full Text]  
• Brady, A J B, Oliver, M A, Pittard, J B (2001). Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care. BMJ 322: 1463-1463 [Full Text]  
• Moher, M., Yudkin, P., Wright, L., Turner, R., Fuller, A., Schofield, T., Mant, D. (2001). Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ 322: 1338-1338 [Abstract] [Full Text]  
• Ayanian, J. Z., Quinn, T. J. (2001). Quality Of Care For Coronary Heart Disease In Two Countries. Health Aff (Millwood) 20: 55-67 [Abstract] [Full Text]  
• Fox, K F, Nuttall, M, Wood, D A, Wright, M, Arora, B, Dawson, E, Devane, P, Stock, K, Sutcliffe, S J, Brown, K (2001). A cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease. Heart 85: 533-538 [Abstract] [Full Text]  
• (2001). Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22: 554-572 [Abstract]  
• Monkman, D (2000). Treating dyslipidaemia in primary care. BMJ 321: 1299-1300 [Full Text]  
• Batalla, A., Hevia, S., Reguero, J. R., Cubero, G. I. (2000). Underutilization of Lipid-Lowering Therapy in Coronary Artery Disease. Arch Intern Med 160: 2683-2684 [Full Text]  
• Gray, J., Majeed, A., Kerry, S., Rowlands, G. (2000). Identifying patients with ischaemic heart disease in general practice: cross sectional study of paper and computerised medical records. BMJ 321: 548-550 [Abstract] [Full Text]  
• Vicari, R. M., Wan, G. J., Aura, A. M., Alexander, C. M., Markson, L. E., Teutsch, S. M., for the Simvastatin Combined Hyperlipidemia Regist, (2000). Use of Simvastatin Treatment in Patients With Combined Hyperlipidemia in Clinical Practice. Arch Fam Med 9: 898-905 [Abstract] [Full Text]  
• Stubbs, P. J., Al-Obaidi, M. K., Conroy, R. M., MusB, , Collinson, P. O., MRCPath, , Graham, I. M., FRCPI, , Noble, M. I. M. (2000). Effect of Plasma Homocysteine Concentration on Early and Late Events in Patients With Acute Coronary Syndromes. Circulation 102: 605-610 [Abstract] [Full Text]  
• Irving, R J., Oram, S H., Boyd, J., Rutledge, P., McRae, F., Bloomfield, P. (2000). Ten year audit of secondary prevention in coronary bypass patients. BMJ 321: 22-23 [Full Text]  
• ISLES, C. G, NORRIE, J. (2000). Lipid lowering drugs for patients who continue to smoke?. Heart 83: 619-620 [Full Text]  
• Montaye, M., De Bacquer, D., De Backer, G., Amouyel, P. (2000). Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J 21: 808-813 [Abstract]  
• Stafford, R. S. (2000). Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease. Circulation 101: 1097-1101 [Abstract] [Full Text]  
• Awtry, E. H., Loscalzo, J. (2000). Aspirin. Circulation 101: 1206-1218 [Full Text]  
• Smithard, D.G., Perez, I., Kalra, L. (2000). Secular trends in the management of hypertension and atrial fibrillation in patients presenting with stroke. QJM 93: 41-44 [Abstract] [Full Text]  
• Capewell, S, Pell, J.P, Morrison, C, McMurray, J (1999). Increasing the impact of cardiological treatments. How best to reduce deaths. Eur Heart J 20: 1386-1392 [Abstract]  
• Melville, M R, Packham, C, Brown, N, Weston, C, Gray, D (1999). Cardiac rehabilitation: socially deprived patients are less likely to attend but patients ineligible for thrombolysis are less likely to be invited. Heart 82: 373-377 [Abstract] [Full Text]  
• Timmis, A. D (1999). Treatment of myocardial infarction should be audited before heart failure clinics are set up. BMJ 319: 123-123 [Full Text]  
• Turner, B. J., Newschaffer, C. J., Zhang, D., Fanning, T., Hauck, W. W. (1999). Translating Clinical Trial Results into Practice: The Effect of an AIDS Clinical Trial on Prescribed Antiretroviral Therapy for HIV-Infected Pregnant Women. ANN INTERN MED 130: 979-986 [Abstract] [Full Text]  
• Bradley, F., Cupples, M. E (1999). Reducing the risk of recurrent coronary heart disease. BMJ 318: 1499-1500 [Full Text]  
• BURGESS;, M. I, KHONG, T. K (1999). The use of statins following AMI. Postgrad. Med. J. 75: 382a-382 [Full Text]  
• Flanagan, D.E.H., Cox, P., Paine, D., Davies, J., Armitage, M. (1999). Secondary prevention of coronary heart disease in primary care: a healthy heart initiative. QJM 92: 245-250 [Abstract] [Full Text]  
• Clark, A.L., Byrne, J.C., Nasser, A., McGroarty, E., Kennedy, J.A. (1999). Cholesterol in peripheral vascular disease—a suitable case for treatment?. QJM 92: 219-222 [Abstract] [Full Text]  
• Capewell, S, Morrison, C E, McMurray, J J (1999). Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81: 380-386 [Abstract] [Full Text]  
• Jolly, K., Bradley, F., Sharp, S., Smith, H., Thompson, S., Kinmonth, A.-L., Mant, D. (1999). Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). BMJ 318: 706-711 [Abstract] [Full Text]  
• Bradley, F., Wiles, R., Kinmonth, A.-L., Mant, D., Gantley, M. (1999). Development and evaluation of complex interventions in health services research: case study of the Southampton heart integrated care project (SHIP). BMJ 318: 711-715 [Full Text]  
• Ferner, R E, Bethell, H. J N (1998). Secondary prevention in coronary heart disease. BMJ 317: 1592-1592 [Full Text]  
• The Long-Term Intervention with Pravastatin in Isc, (1998). Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels. NEJM 339: 1349-1357 [Abstract] [Full Text]  
• Campbell, N C, Ritchie, L D, Thain, J, Deans, H G, Rawles, J M, Squair, J L (1998). Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart 80: 447-452 [Abstract] [Full Text]  
• Baxter, C., Jones, R., Corr, L. (1998). Time trend analysis and variations in prescribing lipid lowering drugs in general practice. BMJ 317: 1134-1135 [Full Text]  
• Dormandy, J. A (1998). Rationale for antiplatelet therapy in patients with atherothrombotic disease. Vasc Med 3: 253-255 [Abstract]  
• British Cardiac Society, , British Hyperlipidaemia Association, , British Hypertension Society, , endorsed by the British Diabetic Association, (1998). Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80: 1S-29 [Full Text]  
• Campbell, N. C, Thain, J., Deans, H G., Ritchie, L. D, Rawles, J. M (1998). Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ 316: 1430-1434 [Abstract] [Full Text]  
• Group, R M N. o. b. o. t. U. K. H. A. S. C. (1998). Fatality outside hospital from acute coronary events in three British health districts, 1994-5. BMJ 316: 1065-1070 [Abstract] [Full Text]  
• Kalra, L., Perez, I., Melbourn, A. (1998). Stroke Risk Management : Changes in Mainstream Practice. Stroke 29: 53-57 [Abstract] [Full Text]  
• Moher, M., Schofield, T., Fullard, E. (1997). Managing established coronary heart disease. BMJ 315: 69-70 [Full Text]  
• Pearson, T. A., Myerson, M. (1997). Treatment of Hypercholesterolemia in Women: Equality, Effectiveness, and Extrapolation of Evidence. JAMA 277: 1320-1321 [Abstract]